The pharmaceutical giant is slashing 11% of its workforce as it continues to lose market share. Novo Nordisk, the Danish ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The company, which is also known for its Ozempic diabetes treatment, already said in August that it had implemented a ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

Investors favor Eli Lilly (LLY), but I argue that Novo (NVO) stock outperforms LLY in almost every aspect while trading at a ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

Novo Nordisk will cut 9,000 jobs in a global restructuring, targeting annual savings of $1.26 billion, as it faces ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 11.5% of its workforce in an ...

Novo Nordisk said the job cuts will eliminate about 11% of its workforce, with 5,000 of the reductions in Denmark.